Results 101 to 110 of about 4,241 (120)

Hyperapobetalipoproteinemia With Compositional Abnormality of LDL and IDL, a Characteristic Lipoprotein Alteration in Essential Hypertension

Hyperapobetalipoproteinemia With Compositional Abnormality of LDL and IDL, a Characteristic Lipoprotein Alteration in Essential Hypertension
openaire  

2025 Egyptian guidelines for the management of dyslipidemia. [PDF]

Egypt Heart J
Reda A, Taha HS, Badran HM, Khamis H, Kamal S, Elserafy AS, Dawoud MH, Elamragy AA, Bendary A, Shaker MM.   +9 more
europepmc   +1 more source

Effect of Hormone Therapy on Lipoprotein Subfractions in Early and Late Postmenopausal Women.

J Clin Endocrinol Metab
Sriprasert I, Kim SS, Mohammed IE, Kono N, Karim R, Allayee H, Hodis HN, Mack WJ, Krauss RM.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cellular metabolism of human plasma intermediate-density lipoprotein (IDL)

Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
The cellular metabolism of human plasma intermediate-density lipoprotein (IDL) was investigated in cultured human skin fibroblasts and hepG-2 cell in the absence and presence of exogenous recombinant or plasmatic apo E-3. IDL (d 1.006-1.019 g/ml) and LDL (d 1.019-1.063 g/ml) were prepared by centrifugation from the plasma of apo E-3/3 or 4/3 ...
G, Friedman, D, Gavish, T, Vogel, S, Eisenberg   +3 more
openaire   +2 more sources

Increased transport of intermediate density lipoprotein (IDL) with cholesterol loading

Metabolism, 1983
Although cholesterol loading in man generally leads to an increase in plasma cholesterol and low density lipoprotein cholesterol in particular, the mechanism for this is unknown. Because IDL formation rises in cholesterol-fed rats we have measured the transport of IDL apoprotein B in 8 men during two dietary periods containing either 200 mg or 1700 mg ...
Paul J. Nestel, Timothy Billington
openaire   +1 more source

Influence of early diabetic nephropathy on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition

Atherosclerosis, 1991
The procedure of discontinuous gradient ultracentrifugation (DGU) was used to characterize the influence of early diabetic nephropathy on the composition of very low density lipoprotein (VLDL, flotation density 60-400 Svedberg (Sf) units), low density lipoprotein (LDL, flotation density 0-12 Sf) and subfractions of intermediate density lipoprotein ...
Winocour, Peter H., Durrington, Paul N., Bhatnagar, Deepak, Ishola, Monica, Mackness, Michael, Arrol, Sharon   +5 more
openaire   +2 more sources

Stimulating effect of intermediate-density lipoproteins (IDL) from hyperlipemic plasma on hepatic lipase

Klinische Wochenschrift, 1986
The main lipoprotein density classes, namely very-low-density lipoproteins (VLDL), intermediate-density lipoproteins (IDL), low-density lipoproteins (LDL), high-density lipoproteins2 (HDL2) and HDL3 were investigated with respect to their influence on hepatic lipase (HTGL) activity in vitro.
A, Dzien, C, Breier, H J, Lisch, H, Braunsteiner   +3 more
openaire   +2 more sources

The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in Type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia

Atherosclerosis, 1992
Lipoprotein composition was examined in type 1 diabetic subjects with hypercholesterolaemia +/- hypertriglyceridaemia during a 3-month double-blind placebo controlled assessment of bezafibrate therapy. The predominant effect was on lipoprotein lipid content.
P H, Winocour, P N, Durrington, D, Bhatagnar, M, Ishola, M, Mackness, S, Arrol, D C, Anderson   +6 more
openaire   +2 more sources

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux

Atherosclerosis, 2002
Type IIB hyperlipidemia is associated with premature vascular disease, an atherogenic lipoprotein phenotype characterised by elevated levels of triglyceride-rich VLDL and small dense LDL, together with subnormal levels of HDL. The dose-dependent and independent effects of a potent HMGCoA reductase inhibitor, Atorvastatin, at daily doses of 10 and 40 mg,
Guerin, Maryse, Egger, Pascal, Soudant, Céline, Le Goff, Wilfried, van Tol, Arie, Dupuis, Reynald, Chapman, M.John   +6 more
openaire   +4 more sources